X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (943) 943
Publication (174) 174
Book Chapter (32) 32
Book Review (10) 10
Book / eBook (6) 6
Conference Proceeding (3) 3
Dissertation (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (512) 512
index medicus (507) 507
proximal external region (332) 332
animals (306) 306
female (179) 179
hiv-1 - immunology (174) 174
male (171) 171
virology (167) 167
hiv (148) 148
immunology (144) 144
immunodeficiency-virus type-1 (140) 140
hiv antibodies - immunology (117) 117
research (116) 116
hiv envelope protein gp41 - immunology (115) 115
viruses (105) 105
antibodies, neutralizing - immunology (104) 104
antibodies (103) 103
physiology (101) 101
amino acid sequence (96) 96
health aspects (95) 95
hiv infections - immunology (95) 95
proteins (93) 93
human-immunodeficiency-virus (92) 92
gp41 (89) 89
orthopedics (88) 88
epitopes - immunology (87) 87
molecular sequence data (87) 87
aids vaccines - immunology (86) 86
surgery (86) 86
human monoclonal-antibodies (85) 85
hiv-1 (84) 84
vaccines (84) 84
proximal femur (82) 82
adult (80) 80
hiv envelope protein gp41 - chemistry (80) 80
neutralization tests (80) 80
article (79) 79
infectious diseases (79) 79
envelope glycoprotein (78) 78
virus diseases (77) 77
human monoclonal-antibody (76) 76
mice (75) 75
middle aged (75) 75
biochemistry & molecular biology (74) 74
multidisciplinary sciences (74) 74
research article (74) 74
aged (73) 73
analysis (73) 73
broadly neutralizing antibodies (72) 72
physiological aspects (72) 72
fractures (69) 69
medicine (69) 69
antibodies, monoclonal - immunology (67) 67
biology (66) 66
human immunodeficiency virus--hiv (66) 66
cell biology (65) 65
antigenic determinants (63) 63
neutralizing antibodies (63) 63
monoclonal antibodies (57) 57
peptides (57) 57
hiv infections - virology (56) 56
viral antibodies (56) 56
aids vaccines (55) 55
care and treatment (55) 55
cell line (54) 54
monoclonal-antibodies (54) 54
epitopes (51) 51
glycoprotein gp41 (50) 50
hiv infections - prevention & control (49) 49
hiv-1 - genetics (49) 49
epitope (48) 48
science (48) 48
rats (47) 47
epitopes - chemistry (46) 46
urology & nephrology (46) 46
immunization (45) 45
medicine, research & experimental (45) 45
membrane (45) 45
microbiology (45) 45
vaccine design (45) 45
kidney tubules, proximal - metabolism (44) 44
proximal tubule (44) 44
aged, 80 and over (43) 43
hiv envelope protein gp41 - genetics (43) 43
immunoglobulins (43) 43
kidney (43) 43
biophysics (42) 42
hiv envelope protein gp120 - immunology (41) 41
engineering, biomedical (40) 40
glycoproteins (40) 40
hiv envelope protein gp41 - metabolism (40) 40
in-vitro (40) 40
protein conformation (40) 40
human immunodeficiency virus (39) 39
infections (39) 39
antigens (38) 38
models, biological (38) 38
models, molecular (38) 38
neutralization (38) 38
vaccine (38) 38
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Vaccine, ISSN 0264-410X, 2017, Volume 35, Issue 20, pp. 2736 - 2744
Highlights • Secreted forms of HIV-1 gp41 ectodomain can be produced using mammalian cells. • Point mutations in gp41 MPER can increase secretion from... 
Allergy and Immunology | HIV-1 | DNA vaccine | Membrane-proximal external region | gp41 | Broadly neutralizing antibodies | MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNE-RESPONSE | NEUTRALIZING ANTIBODIES | POTENT NEUTRALIZATION | HUMAN MONOCLONAL-ANTIBODY | BROAD | IMMUNOLOGY | VIRUS TYPE-1 ENVELOPE | EPITOPE | STRUCTURAL BASIS | PROTEINS | AGGREGATION | HIV Antibodies - blood | Vaccines, DNA - genetics | HIV Envelope Protein gp41 - genetics | Human Development | HIV Envelope Protein gp41 - immunology | Humans | Vaccines, Synthetic - genetics | AIDS Vaccines - immunology | Vaccines, DNA - immunology | Vaccines, Synthetic - immunology | HIV-1 - genetics | Vaccines, DNA - administration & dosage | HIV-1 - immunology | Animals | AIDS Vaccines - genetics | Female | Mice, Inbred BALB C | Vaccines, Synthetic - administration & dosage | AIDS Vaccines - administration & dosage | Vaccines | HIV (Viruses) | DNA | Cells | Protein binding | Proteins | Antigens | Gene mutations | Analysis | Cell culture | Medical research | Immunoglobulins | Glycoprotein gp41 | Peptides | Secretion | Cloning | Antibodies | Envelope protein | Viruses | DNA vaccines | Hydrophobicity | C-Terminus | Mutants | Mammalian cells | Conserved sequence | Clonal deletion | Immunogenicity | Human immunodeficiency virus--HIV | Mutation | Deoxyribonucleic acid--DNA
Journal Article
Current Opinion in HIV and AIDS, ISSN 1746-630X, 05/2017, Volume 12, Issue 3, pp. 250 - 256
PURPOSE OF REVIEWWe summarize the latest research on the progress to understand the neutralizing epitopes present within the membrane proximal external region... 
ECTODOMAIN REGION | 2F5 | INFECTIOUS DISEASES | FUSION | 10E8 | Gp41 | HIV-1 GP41 | 4E10 | TRANSMEMBRANE DOMAIN | IMMUNOLOGY | EPITOPE | STRUCTURAL BASIS | ENVELOPE | IMMUNODEFICIENCY-VIRUS TYPE-1 | membrane proximal external region | MONOCLONAL-ANTIBODIES | CRYO-EM STRUCTURE | Life Sciences | Biomolecules | Biochemistry, Molecular Biology
Journal Article
Vaccine, ISSN 0264-410X, 2013, Volume 31, Issue 46, pp. 5422 - 5429
Highlights • Chimeric BPV VLP vaccines were constructed to present HIV-1 MPER epitopes. • The induction of systemic and mucosal antibody responses was assessed... 
Allergy and Immunology | HIV-1 | Membrane-proximal external region | Vaccine | Mucosal | Neutralizing antibody | Bovine papillomavirus-like particle | MEDICINE, RESEARCH & EXPERIMENTAL | L1 PROTEIN | HUMAN MONOCLONAL-ANTIBODY | INDUCTION | IMMUNOLOGY | ORAL IMMUNIZATION | BROADLY NEUTRALIZING ANTIBODIES | CELLULAR IMMUNE-RESPONSES | IMMUNODEFICIENCY-VIRUS TYPE-1 | SURFACE-ANTIGEN | INFECTION | HIV Antibodies - blood | HIV Envelope Protein gp41 - genetics | Immunoglobulin G - blood | HIV Envelope Protein gp41 - immunology | AIDS Vaccines - immunology | Immunity, Mucosal | Vaccines, Synthetic - immunology | Papillomaviridae - genetics | Drug Carriers | Epitopes - immunology | Immunoglobulin A, Secretory - blood | Vaccines, Virus-Like Particle - genetics | Cattle | Female | HIV Antibodies - analysis | Administration, Oral | Vaccines, Synthetic - genetics | Immunoglobulin A, Secretory - analysis | Epitopes - genetics | HIV-1 - genetics | HIV-1 - immunology | Vaccines, Virus-Like Particle - administration & dosage | Animals | AIDS Vaccines - genetics | Vaccines, Virus-Like Particle - immunology | Mice | Mice, Inbred BALB C | Vaccines, Synthetic - administration & dosage | AIDS Vaccines - administration & dosage | HIV (Viruses) | Immunoglobulin G | Antigenic determinants | Mutation | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Rodents | neutralizing antibody | membrane-proximal external region | vaccine | bovine papillomavirus-like particle | mucosal
Journal Article
Journal Article
Vaccine, ISSN 0264-410X, 2006, Volume 24, Issue 4, pp. 435 - 442
Journal Article
JOURNAL OF CLINICAL INVESTIGATION, ISSN 0021-9738, 06/2015, Volume 125, Issue 6, pp. 2532 - 2546
Cyclic dinucleotides (CONS) are agonists of stimulator of IFN genes (STING) and have potential as vaccine adjuvants. However, cyclic di-GMP (cdGMP) injected... 
NONHUMAN-PRIMATES | MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNE-RESPONSE | CYCLIC-DI-GMP | T-CELL RESPONSES | PROXIMAL EXTERNAL REGION | I INTERFERON RESPONSE | BACTERIAL 2ND-MESSENGER | ANTIBODY-RESPONSES | SYNTHETIC VACCINES | MUCOSAL ADJUVANT
Journal Article
Journal Article